Replies to post #86954 on PharmaCyte Biotech Inc (PMCB)

[Basil22]

I have been long for over 3 years
and I'm not reacting to rumors.
The reality is that PMCB has a little over 1M in cash (not enough for research)
and shows 848,000,000 shares outstanding.
The standard strategy for small biotechs is to do the r/s
and then sell more shares to raise capital.
What is PMCBs plan to fund the testing?
Can it be done without r/s?
Trying to understand the immediate future.